Patents Assigned to Vallon Pharamaceuticals, Inc.
  • Compositions and methods of treating cognitive impairment
    Patent number: 11253490
    Abstract: The present invention relates generally method of treating or alleviating cognitive impairment by administering an abuse-deterrent formulation containing dextroamphetamine sulfate.
    Type: Grant
    Filed: May 17, 2021
    Date of Patent: February 22, 2022
    Assignee: Vallon Pharamaceuticals, Inc.
    Inventors: Ofir Levi, David Baker, Timothy Whitaker